MIRA INFORM REPORT
|
Report No. : |
302753 |
|
Report Date : |
12.01.2015 |
IDENTIFICATION DETAILS
|
Name : |
ZHEJIANG MEDICINES & HEALTH PRODUCTS IMPORT & EXPORT CO., LTD. |
|
|
|
|
Registered Office : |
Zmc Building, No. 101-2, Zhongshan North Road, Hangzhou, Zhejiang Province, 310003 PR |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
29.06.1999 |
|
|
|
|
Com. Reg. No.: |
330000000009213 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Subject is operating medical equipment (range see "Medical Device Distribution Enterprise License", valid period as of May 26, 2019); wholesale of pharmaceutical (range See "Drug License", valid period as of November 22, 2014), wholesale of hazardous chemicals (see "People's Republic of China dangerous chemicals business license", valid period as of September 23, 2015) (no storage); non-pharmaceutical precursor chemicals business (see the range of "non-pharmaceutical precursor chemicals proven operating record "is valid as of September 8, 2016 and" non-pharmaceutical precursor chemicals business license ", valid period as of October 11, 2015), sales of pre-packaged foods, dairy products (including infant formula milk powder) (with "food distribution license" business, valid period as of November 13, 2015). Import and export business. |
|
|
|
|
No of Employees : |
288 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2014
|
Country Name |
Previous Rating (30.06.2014) |
Current Rating (30.09.2014) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
CHINA ECONOMIC OVERVIEW
Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. After keeping its currency tightly linked to the US dollar for years, in July 2005 China moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation and expanded the daily trading band within which the RMB is permitted to fluctuate. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2013 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic consumption; (b) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and increasing numbers of college graduates; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. Several factors are converging to slow China's growth, including debt overhang from its credit-fueled stimulus program, industrial overcapacity, inefficient allocation of capital by state-owned banks, and the slow recovery of China's trading partners. The government's 12th Five-Year Plan, adopted in March 2011 and reiterated at the Communist Party's "Third Plenum" meeting in November 2013, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent in the future on fixed investments, exports, and heavy industry. However, China has made only marginal progress toward these rebalancing goals. The new government of President XI Jinping has signaled a greater willingness to undertake reforms that focus on China's long-term economic health, including giving the market a more decisive role in allocating resources
|
Source
: CIA |
COMPANY
NAME & ADDRESS
ZHEJIANG MEDICINES & HEALTH PRODUCTS IMPORT
& EXPORT CO., LTD.
ZMC BUILDING, NO. 101-2, ZHONGSHAN NORTH ROAD, HANGZHOU,
ZHEJIANG PROVINCE, 310003 PR CHINA
TEL: 86 (0) 571-28935716/28935717
FAX: 86 (0) 571-87016777
EXECUTIVE
SUMMARY
INCORPORATION DATE :
JUNE 29, 1999
REGISTRATION NO. :
330000000009213
REGISTERED LEGAL FORM : LIMITED LIABILITIES COMPANY
STAFF STRENGTH :
288
REGISTERED CAPITAL : CNY 80,000,000
BUSINESS LINE :
TRADING
TURNOVER :
CNY 4,479,520,000 (AS OF DEC.
31, 2013)
EQUITIES :
CNY 345,680,000 (AS OF DEC. 31, 2013)
PAYMENT :
AVERAGE
MARKET CONDITION :
COMPETITIVE
FINANCIAL CONDITION :
FAIRLY STABLE
OPERATIONAL TREND : STEADY
GENERAL REPUTATION :
WELL-KNOWN
EXCHANGE RATE :
CNY 6.17 =USD 1
Adopted
abbreviations:
ANS – Amount not
stated
NS – Not stated
SC – Subject
company (the company inquired by you)
NA – Not available
CNY – China Yuan Renminbi
SC was registered as a limited liabilities
company at Zhejiang Provincial Administration for Industry & Commerce (The
official body of issuing and renewing business license) on June 29, 1999.
Company Status: Limited Liabilities Co. This form of business in PR
China is defined as a legal person. No more than fifty shareholders
contribute its registered capital jointly. Shareholders bear limited
liability to the extent of shareholding, and the co. is liable for its
debts only to extent of its total assets. The characteristics of this form
of co. are as follows: Upon the establishment of the
co., an investment certificate is issued to the each of shareholders. The board of directors is
comprised of three to thirteen members. The minimum registered capital
for a co. is CNY 30,000. Shareholders may take their
capital contributions in cash or by means of tangible assets or intangible
assets such as industrial property and non-patented technology. Cash contributed by all
shareholders must account for at least 30% of the registered capital. Existing shareholders have
pre-exemption right to purchase shares of the co. offered for sale by the
other shareholders and to subscribe for the newly increased registered
capital of the co.
SC’s registered
business scope includes operating medical equipment (range see "Medical
Device Distribution Enterprise License", valid period as of May 26, 2019);
wholesale of pharmaceutical (range See "Drug License", valid period
as of November 22, 2014), wholesale of hazardous chemicals (see "People's
Republic of China dangerous chemicals business license", valid period as
of September 23, 2015) (no storage); non-pharmaceutical precursor chemicals
business (see the range of "non-pharmaceutical precursor chemicals proven
operating record "is valid as of September 8, 2016 and"
non-pharmaceutical precursor chemicals business license ", valid period as
of October 11, 2015), sales of pre-packaged foods, dairy products (including
infant formula milk powder) (with "food distribution license"
business, valid period as of November 13, 2015). Import and export business.
SC is mainly engaged
in trading of medical supplies and instruments.
Mr. Chen
Zhangsheng has been legal representative and chairman of SC since April of
2010.
SC is known to
have approx. 288 employees at present.
SC
is currently operating at the above stated address, and this address houses its
operating office in the commercial zone of Hangzhou. Our checks reveal that SC
owns the total premise about 2,000 square meters.
http://www.zmchealthcare.com
The design is professional and the content is well organized. At present the
web site is only in English version.
Email: liyangming@zmcchina.com
SC obtained GSP Certificate, ISO Certificate and JAS Certificate.
Changes
of its registered information are as follows:
|
Date of change |
Item |
Before the
change |
After the change |
|
2000-06-19 |
Registered capital |
CNY 43,000,000 |
CNY 47,437,000 |
|
2002-01-21 |
Registered capital |
CNY 47,437,000 |
CNY 55,455,500 |
|
2002-07-10 |
Registered capital |
CNY 55,455,500 |
CNY 61,069,375 |
|
2003-07-18 |
Registered capital |
CNY 61,069,375 |
CNY 65,000,000 |
|
2004-08-04 |
Registered capital |
CNY 65,000,000 |
CNY 69,000,000 |
|
2005-09-05 |
Registered capital |
CNY 69,000,000 |
CNY 40,000,000 |
|
2006-08-10 |
Registered capital |
CNY 40,000,000 |
CNY 56,000,000 |
|
Registered capital |
CNY 56,000,000 |
CNY 63,000,000 |
|
|
2007-10-11 |
Registration no. |
3300001005837 |
The present one |
|
2009-08-26 |
Registered capital |
CNY 63,000,000 |
CNY 70,000,000 |
|
2010-04-06 |
Legal representative |
Li Fusheng |
The present one |
|
2011-10-13 |
Registered capital |
CNY 70,000,000 |
Present amount |
|
Shareholders |
Employee Shareholders Association 45.27%;
Zhejiang International Business Group Co., Ltd. 30.00%; Chen Zhangsheng
1.30%; Li Fusheng 1.25%; Li Lin 1.23%; Wang Ping 1.23% Liu Junguang 0.99%; Other 36 individuals
36 18.73% |
Employee Shareholders Association 47.72% Zhejiang International Business Group Co., Ltd. 33.50% Chen Zhangsheng 1.14% Li Lin 1.08% Wang Ping 1.08% Liu Junguang 0.86% Other 33 individuals 14.62% |
|
|
2012-8-3 |
Shareholders |
Employee Shareholders Association 47.72% Zhejiang International Business Group Co., Ltd. 33.50% Chen Zhangsheng 1.14% Li Lin 1.08% Wang Ping 1.08% Liu Junguang 0.86% Other 33 individuals 14.62% |
Employee Shareholders Association 49.23% Zhejiang International Business Group Co.,
Ltd. 33.50% Chen Zhangsheng 1.14% Li Lin 1.08% Liu Junguang 0.86% Bai Minzi 1.17% Other 31 individuals 13.02% |
|
2013-06-19 |
Shareholders |
Employee Shareholders Association 49.23% Zhejiang International Business Group Co.,
Ltd. 33.50% Chen Zhangsheng 1.14% Li Lin 1.08% Liu Junguang 0.86% Bai Minzi 1.17% Other 31 individuals 13.02% |
Present ones |
Subject passed the annual inspection of 2012
with Administration for Industry & Commerce.
Organization Code: 142912646
For the past two years there is no record of litigation.
MAIN SHAREHOLDERS:
Name Amount (CNY’0000) %
of Shareholding
Employee Shareholders Association 4,032.8842 50.4111
Zhejiang International Business Group Co.,
Ltd. 2,680 33.5
Hu Shunliang 2.4 0.03
Zhao Xuan 7.675 0.0959
Jia Dagan 8.6813 0.1085
Huang Changbin 9.475 0.1184
Yu Yijun 11.125 0.1391
Zhu Sheng 14.175 0.1772
Yao Hua 18.9313 0.2366
Xie Chunyan 19.4906 0.2436
Chen Zhigang 20.25 0.2531
Ye Ting 20.9313 0.2616
Gu Senjuan 24.025 0.3003
Fang Jianyang 25.3406 0.3168
Yu Yao 28.7219 0.359
Ma Aiqun 31.4156 0.3927
Xiao Changming 33.6656 0.4208
Tang Xiaolan 37.0375 0.463
Wang Yide 39.2625
0.4908
Qian Shuyao 42.3563 0.5295
Liu Wenhua 42.7406 0.5343
Sheng Chunsheng 44.0719 0.5509
Shen Gang 46.25 0.5781
Xu Wenhui 48.5281 0.6066
Hou Honghao 48.7156 0.6089
Yang Baohua 50.8781 0.636
Tan Jian 52.625 0.6578
Xu Xiaodan 54.2938 0.6787
Yao Zhaili 54.6063 0.6826
Huang Hai 56.625 0.7078
Ma Zhengming 66.7281 0.8341
Liu Junguang 69.1125 0.8639
Zhao Xiaogang 72.6281 0.9079
Chen Zhangsheng 90.8438 1.1355
Bai Minzi 93.5094 1.1689
Zhejiang International Business Group Co.,
Ltd.
===================================
Zhejiang International Business Group Co.,
Ltd. was established in 2008, a solely state-owned company invested by Zhejiang
People’s Government. Under the supervision and administration of Zhejiang
State-owned Asset Supervision and Administration Commission ZIB acts of the
capacity of state-owned fund provider responsible for value maintenance and
increase of the state-owned asset.
Registered no.: 330000000018008
Registered capital: CNY 980,000,000
Legal representative: Ding Kangsheng
Legal form: Sole state-owned enterprise
Tel: 86-571- 87385955
Fax: 86-571-87385988
E-mail: service@zibchina.com
Website: http://www.zibchina.com
l
Legal representative and Chairman:
Mr. Chen Zhangsheng, born in 1956, with university education. He is currently responsible for the overall
management of SC.
Working Experience(s):
From 1999 to April of 2010 Worked in SC as
vice chairman and general manager;
From April of 2010 to present Working in SC
as legal representative and chairman.
Also
working in Zhejiang Yibao Health Products Co., Ltd., Zhejiang Shangshang Medicine
and Health Products Co., Ltd. and Zhejiang
Hisun Chemical Co., Ltd. as legal representative, etc.
l
Vice Chairman & General manager:
Mr. Zhao Xiaogang, born in 1958, he is currently responsible for the
overall and daily management of SC.
Working Experience(s):
At present Worked in SC as vice chairman and
general manager.
l
Vice Chairman:
Ms. Yuan Chenghai, born in 1977, she is currently responsible for the
overall management of SC.
Working Experience(s):
At present Worked in SC as vice chairman.
l Directors:
Chen Lu
Tang Xiaolan
Liu Junguang
Huang Hai
l Supervisors:
Zhu Sheng
Chen Leqian
Gong Yougen
SC is mainly
engaged in trading of medical supplies and instruments.
SC’s products
mainly include:
Urological
Surgical Suction
Management
Kit Treatment
Diagnostic
Products
Basic Dressing
Ostomy Care
Wound Care
Enteral Feeding
Endoscope Products
& Medical Stents
Electric Supplies
Electrosurgery
First Aid Kits
Gynecological
Homecare
IV Solution
Lab Specimen
Collection
Medical Plastic
Products
Medical Equipment
Personal
Protection
Sports
support
Trademarks &
Patents
Registration No.: 10121671
Registration Date: Dec. 21, 2012
Trademark Design: 
Registration No.: 9861690
Registration Date: Sep. 14, 2013
Trademark Design: 
Registration No.: 9268361
Registration Date: Jun. 14, 2012
Trademark Design: 
SC sources its
materials 90% from domestic market, and 10% from U.S.A. and Europe. SC sells
20% of its products in domestic market, and 80% to Asian, Europe, America, etc.
The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days.
The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.
Note: SC refused to release its main customers and
suppliers.
SC
is known to invest in the following companies:
Zhejiang
Yibao Health Products Co., Ltd.
=============================
Incorporation date: 2007-8-13
Registered no.: 330000000004540
Legal representative: Chen Zhangsheng
Legal form: One-person Limited Liability
Company
Zhejiang
International Business Group Logistics Co., Ltd.
========================================
Incorporation date: 1993-6-2
Registered no.: 330000000035693
Legal representative: Wu Xingguo
Legal form: Limited liabilities co.
E-mail: gmwl2009@gmail.com
Tel: 86-571-85779795
Fax: 86-571-85779652
Zhejiang
Shangshang Medicine and Health Products Co., Ltd.
=============================================
Incorporation date: 2011-6-8
Registered no.: 330000000058051
Legal representative: Chen Zhangsheng
Legal form: One-person Limited Liability
Company
Web: http://www.zjss.com
Ningbo
Huana Chemical Co., Ltd.
========================
Incorporation date: 2001-6-19
Registered no.: 330211000014597
Registered capital: CNY 1,500,000
Legal representative: Hu Jinda
Legal form: Limited liabilities co.
E-mail: huanachem@163.com
Tel: 86-574-86509690/86509691
Fax: 86-574-86502089
Zhejiang Hisun Chemical Co., Ltd.
=========================
Incorporation
date: 1998-12-4
Registered
capital: CNY 85,000,000
Legal representative: Chen Zhangsheng
Legal form: Shares limited co.
E-mail: sales.intl@hisunchem.com
Tel: 86-576-88827793
Fax: 86-576-88827789
Pinghu
Xinjiyuan Raiment Co., Ltd.
=========================
Incorporation date: 2006-3-1
Registered no.: 330482000052672
Legal representative: Hou Honghao
Legal form: Limited liabilities co.
Etc.
Zhejiang Medicines & Health Products Import & Export Co., Ltd.
Xiaoshan Branch
==========================================================
Incorporation date: 2011-1-4
Registered no.: 330181000232932
Principal: Yao Zhaili
Overall payment appraisal:
( ) Excellent (
) Good (X) Average (
) Fair ( ) Poor
( ) Not yet determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment
experience (through current enquiry with SC's suppliers), our delinquent
payment and our debt collection record concerning SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent
payment record: None in our database.
Debt collection record: No overdue amount owed by SC was placed to us for
collection within the last 6 years.
Bank of China Zhejiang Province Branch
AC#:
361058326683
Relationship:
Normal.
Balance Sheet
Unit: CNY’000
|
|
As
of Dec. 31, 2012 |
As
of Dec. 31, 2013 |
|
Cash & bank |
39,910 |
33,050 |
|
Trading
financial assets |
5,330 |
0 |
|
Inventory |
202,490 |
305,590 |
|
Accounts
receivable |
501,110 |
649,650 |
|
Export tax
rebates receivable |
26,190 |
0 |
|
Other Accounts
receivable |
69,790 |
82,040 |
|
Advances to
suppliers |
58,030 |
60,230 |
|
Other current
assets |
0 |
1,840 |
|
|
------------------ |
------------------ |
|
Current assets |
902,850 |
1,132,400 |
|
Fixed assets net
value |
14,980 |
11,650 |
|
Projects under
construction |
9,260 |
9,260 |
|
Long term
investments |
83,840 |
75,970 |
|
Financial assets
available for sale |
7,080 |
0 |
|
Long-term
deferred expenses |
2,740 |
0 |
|
Intangible
assets |
0 |
0 |
|
Deferred assets
debits |
5,530 |
8,130 |
|
Other assets |
0 |
8,320 |
|
|
------------------ |
------------------ |
|
Total assets |
1,026,280 |
1,245,730 |
|
|
============= |
============= |
|
Short loans |
141,340 |
411,050 |
|
Notes payable |
345,740 |
290,010 |
|
Accounts payable |
139,290 |
121,090 |
|
Other Accounts
payable |
5,790 |
2,350 |
|
Advances from
clients |
105,210 |
141,920 |
|
Employee pay
payable |
5,630 |
6,050 |
|
Tax payable |
-29,780 |
-72,400 |
|
Other current
liabilities |
0 |
-20 |
|
|
------------------ |
------------------ |
|
Current
liabilities |
713,220 |
900,050 |
|
Other
liabilities |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total
liabilities |
713,220 |
900,050 |
|
Equities |
313,060 |
345,680 |
|
|
------------------ |
------------------ |
|
Total
liabilities & equities |
1,026,280 |
1,245,730 |
|
|
============= |
============= |
Income Statement
Unit: CNY’000
|
|
As of Dec. 31,
2012 |
As of Dec. 31, 2013 |
|
Turnover |
3,805,480 |
4,479,520 |
|
Cost of goods sold |
3,623,250 |
4,300,900 |
|
Taxes and additional of main operation |
750 |
1,290 |
|
Sales expense |
57,820 |
76,810 |
|
Management expense |
58,000 |
60,740 |
|
Finance expense |
-23,820 |
-57,260 |
|
Impairment of assets |
1,340 |
9,430 |
|
Sound value
flexible profit |
80 |
-80 |
|
Investment
income |
6,180 |
23,090 |
|
Non-operation
income |
8,720 |
4,960 |
|
Non-operation expense |
3,880 |
1,040 |
|
Profit before
tax |
7,541,680 |
8,900,440 |
|
Less: profit tax |
25,250 |
29,070 |
|
Profits |
73,990 |
85,470 |
Important Ratios
=============
|
|
as
of Dec. 31, 2012 |
as
of Dec. 31, 2013 |
|
*Current ratio |
1.27 |
1.26 |
|
*Quick ratio |
0.98 |
0.92 |
|
*Liabilities
to assets |
0.69 |
0.72 |
|
*Net profit
margin (%) |
1.94 |
1.91 |
|
*Return on
total assets (%) |
7.21 |
6.86 |
|
*Inventory
/Turnover ×365 |
20 days |
25 days |
|
*Accounts
receivable/Turnover ×365 |
49 days |
53 days |
|
*Turnover/Total
assets |
3.71 |
3.60 |
|
* Cost of
goods sold/Turnover |
0.95 |
0.96 |
PROFITABILITY:
FAIRLY GOOD
l The turnover of SC
appears good in its line, and appears a rising trend.
l SC’s net profit
margin is average.
l SC’s return on
total assets is fairly good.
l
SC’s cost of goods sold is fairly high, comparing
with its turnover.
LIQUIDITY: AVERAGE
l
The current ratio of SC is maintained in a normal
level.
l
SC’s quick ratio is maintained in a normal level.
l
The inventory of SC appears average in both years.
l
The accounts receivable of SC appears fairly large
in both years.
l
SC’s short loan appears average in 2012 but large
in 2013.
l
SC’s turnover is in a fairly good level, comparing
with the size of its total assets.
LEVERAGE: AVERAGE
l
The debt ratio of SC is average.
l
The risk for SC to go bankrupt is average.
Overall financial
condition of the SC: Fairly Stable.
SC is considered medium-sized in its line with fairly stable financial
conditions. The large amount of accounts receivable and short loan could be a
threat to SC’s financial condition.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.40 |
|
|
1 |
Rs.94.17 |
|
Euro |
1 |
Rs73.61 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.